GoAI
Get started
Sugi Holdings Co.,Ltd. logo

Sugi Holdings Co.,Ltd.

7649.T

JPXHealthcareMedical - Pharmaceuticals

Open in GoAI

Latest quote

¥2,740

+¥25.50 · +0.94%

Aug 24, 3:30 PM JST

7649.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Sugi Holdings Co.,Ltd. operates drugstores in Japan. The company also provides self-care support services, including meal delivery, cancer and other health checkups, specific health guidance, health information, and community comprehensive agreements; health care support, such as medicine support, home-visit dispensing and nursing, prevention programs, shopping assistance, and mobility support services. In addition, it engages in drugstore operation, dispensing pharmacy operation, medical consultation, business in foreign countries, Chinese medicine pharmacy operations, disease prevention and health support, promotion of disabled employment, home visit nursing and elderly home-care support, support for commencement of medical practice, comprehensive staff agency service, and support business for pharmacy operations. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
Headquarters
JP
CEO
Katsunori Sugiura
Listed since
Jul 26, 2001
Employees
13,417

Market position

Day range

Current ¥2,740

52-week range

Current ¥2,740

Open
¥2,708.5
Previous close
¥2,714.5
Volume
1.31M
1.47× average
Average volume
889.89K
Average daily volume
Market cap
509.79B JPY
Beta
0.29
Market reference 1
50-day average
¥2,954.67
-7.27% below average
200-day average
¥3,331.94
-17.77% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
632.51B JPY
P/E (TTM)
16.17×
P/B (TTM)
1.69×
P/S (TTM)
0.49×
EV / EBITDA
9.56×
Earnings yield
6.92%
Free cash flow yield
9.80%
Dividend yield
1.28%

Profitability & efficiency

Gross margin
31.78%
Operating margin
4.86%
Net margin
2.96%
Return on equity
15.49%
Return on assets
7.32%
Return on invested capital
11.80%

Financial health

Debt / equity
0.32×
Current ratio
1.34×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends35%23%12%-0%Gross margin, FY2022: 30.62%Gross margin, FY2023: 30.33%Gross margin, FY2024: 30.74%Gross margin, FY2025: 31.33%Gross margin, FY2026: 31.79%Operating margin, FY2022: 5.14%Operating margin, FY2023: 4.74%Operating margin, FY2024: 4.92%Operating margin, FY2025: 4.85%Operating margin, FY2026: 4.81%Net margin, FY2022: 3.10%Net margin, FY2023: 2.85%Net margin, FY2024: 2.95%Net margin, FY2025: 2.93%Net margin, FY2026: 4.45%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 30.62%. Gross margin FY2023 30.33%. Gross margin FY2024 30.74%. Gross margin FY2025 31.33%. Gross margin FY2026 31.79%. Operating margin FY2022 5.14%. Operating margin FY2023 4.74%. Operating margin FY2024 4.92%. Operating margin FY2025 4.85%. Operating margin FY2026 4.81%. Net margin FY2022 3.10%. Net margin FY2023 2.85%. Net margin FY2024 2.95%. Net margin FY2025 2.93%. Net margin FY2026 4.45%.

Income trends

Revenue

1.01T JPY+15.07%

Operating income

48.57B JPY+14.11%

Net income

44.98B JPY+75.10%
Income trends across reported periods1.11T JPY712.94B JPY316.41B JPY−80.13B JPYRevenue, FY2022: 625.48B JPYRevenue, FY2023: 667.65B JPYRevenue, FY2024: 744.48B JPYRevenue, FY2025: 878.02B JPYRevenue, FY2026: 1.01T JPYOperating income, FY2022: 32.14B JPYOperating income, FY2023: 31.66B JPYOperating income, FY2024: 36.62B JPYOperating income, FY2025: 42.56B JPYOperating income, FY2026: 48.57B JPYNet income, FY2022: 19.39B JPYNet income, FY2023: 19.01B JPYNet income, FY2024: 21.98B JPYNet income, FY2025: 25.69B JPYNet income, FY2026: 44.98B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 625.48B JPY. Revenue FY2023 667.65B JPY. Revenue FY2024 744.48B JPY. Revenue FY2025 878.02B JPY. Revenue FY2026 1.01T JPY. Operating income FY2022 32.14B JPY. Operating income FY2023 31.66B JPY. Operating income FY2024 36.62B JPY. Operating income FY2025 42.56B JPY. Operating income FY2026 48.57B JPY. Net income FY2022 19.39B JPY. Net income FY2023 19.01B JPY. Net income FY2024 21.98B JPY. Net income FY2025 25.69B JPY. Net income FY2026 44.98B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue1.01T JPY878.02B JPY744.48B JPY667.65B JPY625.48B JPY
Cost of goods sold689.13B JPY602.98B JPY515.64B JPY465.12B JPY433.99B JPY
Gross profit321.21B JPY275.04B JPY228.84B JPY202.52B JPY191.49B JPY
Selling, general, and administrative272.64B JPY232.48B JPY192.22B JPY170.87B JPY159.35B JPY
Operating expenses272.64B JPY232.48B JPY192.22B JPY170.87B JPY159.35B JPY
Interest income625M JPY923M JPY602M JPY160M JPY84M JPY
Interest expense881M JPY227M JPY15M JPY16M JPY19M JPY
Depreciation and amortization20.11B JPY17.87B JPY14.12B JPY12.36B JPY11.27B JPY
Operating income48.57B JPY42.56B JPY36.62B JPY31.66B JPY32.14B JPY
Net income44.98B JPY25.69B JPY21.98B JPY19.01B JPY19.39B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
55%
6 beats, 5 misses, 0 met estimates
Average EPS surprise
+16.79%
11 comparable reports
Latest EPS result
38.14
Estimate 42.87 · Miss by 11.03%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates124.0392.016027.98Q1 '25BeatQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26MissQ3 '26Estimate
Q1 2025, reported Jan 9, 2025: actual 33.14, estimate 32.92, surprise +0.67%, Beat. Q2 2025, reported Apr 10, 2025: actual 36.6, estimate 39, surprise -6.15%, Miss. Q3 2025, reported Jul 10, 2025: actual 117.28, estimate 42.45, surprise +176.28%, Beat. Q4 2025, reported Oct 9, 2025: actual 40.85, estimate 48.13, surprise -15.13%, Miss. Q1 2026, reported Jan 8, 2026: actual 38.96, estimate 41.86, surprise -6.93%, Miss. Q2 2026, reported Apr 9, 2026: actual 51.47, estimate 47.43, surprise +8.52%, Beat. Q3 2026, reported Jul 9, 2026: actual 38.14, estimate 42.87, surprise -11.03%, Miss. Q3 2026, reported Sep 29, 2026: actual —, estimate 49.75, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates286.94B257.34B227.74B198.15BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ3 '26Estimate
Q1 2025, reported Jan 9, 2025: actual 220.81B JPY, estimate 209.18B JPY, surprise +5.56%, Beat. Q2 2025, reported Apr 10, 2025: actual 243.4B JPY, estimate 239.5B JPY, surprise +1.63%, Beat. Q3 2025, reported Jul 10, 2025: actual 245.46B JPY, estimate 244.64B JPY, surprise +0.34%, Beat. Q4 2025, reported Oct 9, 2025: actual 254.71B JPY, estimate 257.85B JPY, surprise -1.22%, Miss. Q1 2026, reported Jan 8, 2026: actual 249.96B JPY, estimate 247.85B JPY, surprise +0.85%, Beat. Q2 2026, reported Apr 9, 2026: actual 260.21B JPY, estimate 257.97B JPY, surprise +0.87%, Beat. Q3 2026, reported Jul 9, 2026: actual 274.84B JPY, estimate 267.66B JPY, surprise +2.68%, Beat. Q3 2026, reported Sep 29, 2026: actual —, estimate 275.9B JPY, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Stock splitUpcoming

Effective Aug 28, 2026

2:1

Stock split

Effective Feb 28, 2024

3:1

Stock split

Effective Feb 23, 2006

2:1

Stock split

Effective Feb 24, 2004

2:1

7649.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 7649.T

research.disclaimer